Goldstream Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,838
Closed -$193K 50
2025
Q4
$193K Hold
1,838
0.07% 49
2025
Q3
$154K Hold
1,838
0.03% 47
2025
Q2
$147K Hold
1,838
0.05% 49
2025
Q1
$166K Hold
1,838
0.07% 40
2024
Q4
$184K Sell
1,838
-2,107
-53% -$217K 0.05% 40
2024
Q3
$450K Buy
+3,945
New +$469K 0.15% 38
2023
Q4
Sell
-1,699
Closed -$176K 50
2023
Q3
$176K Hold
1,699
0.14% 37
2023
Q2
$197K Buy
1,699
+496
+41% +$56.3K 0.14% 30
2023
Q1
$128K Buy
+1,203
New +$130K 0.14% 36

Other funds holding MRK

Goldstream Capital Management's MRK Position: Q1 2026 in Review

Goldstream Capital Management sold out of Merck (MRK) in Q1 2026, closing a stake of 1,838 shares — an estimated $193K sold.

Goldstream Capital Management first reported a position in MRK in Q1 2023 and held it in 9 quarters. The position peaked at $450K in Q3 2024. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Goldstream Capital Management reported no remaining Merck position as of Q1 2026 after selling out during the quarter.
  • Goldstream Capital Management sold 1,838 Merck shares in Q1 2026, an estimated $193K.
  • Goldstream Capital Management first reported a position in Merck in Q1 2023 and held it in 9 quarters.
  • Goldstream Capital Management's Merck position peaked at $450K in Q3 2024.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Goldstream Capital Management's 13F filing for Q1 2026, filed 15 May 2026.